Developments in Point-of-Care Diagnostic Technology for Cancer Detection
Cancer is the cause of death for one in seven individuals worldwide. It is widely acknowledged that screening and early diagnosis are of vital importance for improving the likelihood of recovery. However, given the costly, time-consuming, and invasive nature of the many methods currently in use, pat...
Main Authors: | Bryony Hayes, Caroline Murphy, Aoife Crawley, Richard O’Kennedy |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-06-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | http://www.mdpi.com/2075-4418/8/2/39 |
Similar Items
-
Glycosylation in Indolent, Significant and Aggressive Prostate Cancer by Automated High-Throughput <i>N</i>-Glycan Profiling
by: Sarah Gilgunn, et al.
Published: (2020-12-01) -
Enhancement of diagnostic performance in lung cancers by combining CEA and CA125 with autoantibodies detection
by: Ruochuan Zang, et al.
Published: (2019-10-01) -
Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer
by: Yu-Hui Wang, et al.
Published: (2018-03-01) -
Current status of liquid biopsies for the detection and management of prostate cancer
by: Lu YT, et al.
Published: (2019-06-01) -
Association of Circulating Tumor Cells with Inflammatory and Biomarkers in the Blood of Patients with Metastatic Castration-Resistant Prostate Cancer
by: Gerit Theil, et al.
Published: (2021-07-01)